Strategic Partnerships Leverage IIS’s recent collaboration with the National Infusion Center Association to identify policy-driven opportunities and grant access to a broader network of infusion sites for captive pricing agreements and preferred partner programs.

Network Expansion Target the 2,100+ infusion sites and 1,300+ multispecialty centers across allergy, rheumatology, neurology, immunology, gastroenterology, and infectious disease to upsell ASP-based pricing solutions, billing optimization, and access programs that sustain profitability.

Financial Stability Position IIS’s proven profitability support and in-office infusion continuation as a value driver for provider-owned centers seeking cost containment, stable revenue streams, and predictable drug access across high-demand therapies.

Tech-Driven Value Align IIS’s tech stack and customer-facing platforms (AWS, HubSpot, Microsoft 365, CMS) to offer scalable implementation, ERP-like pricing acceleration, and data-driven insights that reduce administrative burden for infusion centers and manufacturers.

Growth Fit Capitalize on IIS’s women-owned, sustainable growth positioning to approach specialty manufacturers and payers seeking equitable access and long-term partnerships, highlighting how joint pricing models support patient access and market expansion.